Transcriptional regulation of the human PRL-releasing peptide (PrRP) receptor gene by a dopamine 2 receptor agonist: Cloning and characterization of the human PrRP receptor gene and its promoter region

Molecular Endocrinology

Volumn 16, Issue 4, 2002, Pages 785-798

  Ozawa, Atsushi ^a   Yamada, Masanobu ^a   Satoh, Teturou ^a   Monden, Tsuyoshi ^a   Hashimoto, Koshi ^a   Kohga, Hideaki ^a   Hashiba, Yasuhiro ^a   Sasaki, Tomio ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FORSKOLIN; GENE PRODUCT; PROLACTIN RELEASING FACTOR; PROTEIN C FOS; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TATA BOX; TRANSCRIPTION REGULATION;

FELIS CATUS;

EID: 0036217993     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.4.0819     Document Type: Article

References (45)

1. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors
2. Sequence and tissue distribution of a candidate G-coupled receptor cloned from rat hypothalamus
3. A prolactin-releasing peptide in the brain
4. Stimulation of prolactin release by prolactin-releasing peptide in rats
5. Prolactin-releasing peptides do not stimulate prolactin release in vivo
6. Gender-biased activity of the novel prolactin releasing peptides: Comparison with thyrotropin releasing hormone reveals only pharmacologic effects
7. Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas
8. Clonal origin of pituitary adenomas
9. Molecular genetics studies of sporadic pituitary tumors
10. Molecular screening of pituitary adenomas for gene mutations and rearrangements
11. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylel cyclase in human pituitary tumours
12. Two G protein oncogenes in human endocrine tumors
13. Altered Gs and adenylyl cyclase activity in human GH-secreting pituitary adenomas
14. Dopamine agonists and pituitary tumor shrinkage
15. Cloning and expression of a rat D2 dopamine receptor cDNA
16. Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion
17. Physiological concentrations of dopamine decrease adenosine 3′,5′-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: Evidence for a causal relationship to inhibition of prolactin release
18. Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion
19. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. Dual signaling pathways required for D2 receptor-regulated expression of the prolactin gene
20. An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells
21. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons
22. Dopamine receptors: From structure to function
23. Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice
24. Cloning and characterization of the 5′-flanking region of the human prolactin-releasing peptide receptor gene
25. Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary
26. In vitro studies on prolactin release and adenylate cyclase activity in human prolactin-secreting pituitary adenomas. Different sensitivity of macro- and microadenomas to dopamine and vasoactive intestinal polypeptide
27. Dopaminergic inhibition of adenylate cyclase correlates with high affinity agonist binding to anterior pituitary D2 dopamine receptors
28. Negative modulator of the rat D2 dopamine receptor gene
29. Regulation of striatal dopamine receptors by estrogen
30. A positive genetic selection for disrupting protein-protein interactions: Identification of CREB mutations that prevent association with the coactivator CBP
31. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
32. Phosphorylated CREB binds specifically to the nuclear protein CBP
33. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor
34. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype
35. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor
36. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery
37. 2+ messenger systems together reverse dopaminergic inhibition of prolactin release
38. 32P incorporation into phosphatidylinositol in the anterior pituitary gland of the rat
39. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: Cloning and functional expression of the human thyrotropin-releasing hormone receptor gene
40. Cloning and structure of human genomic DNA and hypothalamic cDNA encoding human prepro thyrotropin-releasing hormone
41. Genomic organization and promoter function of the mouse uncoupling protein 2 (UCP2) gene
42. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
43. Negative regulation of the gene for the preprothyrotropin-releasing hormone from the mouse by thyroid hormone requires additional factors in conjunction with thyroid hormone receptors
44. DNA binding and interaction with the nuclear receptor corepressor of thyroid hormone receptor are required for ligand-independent stimulation of the mouse preprothyrotropin-releasing hormone gene
45. Stimulation of the preprothyrotropin-releasing hormone gene by epidermal growth factor